Guyasuta Investment Advisors Inc Abbott Laboratories Transaction History

Guyasuta Investment Advisors Inc

$1.51 Billion
Q3 2024

A detailed history of Guyasuta Investment Advisors Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Guyasuta Investment Advisors Inc holds 22,937 shares of ABT stock, worth $2.64 Million. This represents 0.17% of its overall portfolio holdings.

Number of Shares

22,937

Previous 24,015 4.49%

Holding current value

$2.64 Million

Previous $2.5 Million 4.81%

% of portfolio

0.17%

Previous 0.17%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $107,875 - $127,344	-1,078 Reduced 4.49%	22,937 $2.62 Million
Q4 2023 Feb 05, 2024	SELL	$90.19 - $110.4 $901 - $1,104	-10 Reduced 0.04%	24,015 $2.64 Million
Q3 2023 Oct 25, 2023	SELL	$95.53 - $114.62 $10,126 - $12,149	-106 Reduced 0.44%	24,025 $2.33 Million
Q2 2023 Jul 17, 2023	BUY	$100.78 - $112.29 $7,659 - $8,534	76 Added 0.32%	24,131 $2.63 Million
Q4 2022 Jan 30, 2023	BUY	$95.06 - $111.52 $47,530 - $55,760	500 Added 2.12%	24,055 $2.64 Million
Q3 2022 Oct 25, 2022	SELL	$96.76 - $112.03 $15,578 - $18,036	-161 Reduced 0.68%	23,555 $2.28 Million
Q2 2022 Jul 21, 2022	SELL	$102.07 - $123.37 $18,372 - $22,206	-180 Reduced 0.75%	23,716 $2.58 Million
Q1 2022 May 03, 2022	BUY	$114.02 - $139.04 $22,804 - $27,808	200 Added 0.84%	23,896 $2.83 Million
Q4 2021 Feb 08, 2022	SELL	$115.53 - $141.46 $8,549 - $10,468	-74 Reduced 0.31%	23,696 $3.34 Million
Q2 2021 Aug 12, 2021	BUY	$105.79 - $124.53 $7,405 - $8,717	70 Added 0.3%	23,770 $2.76 Million
Q1 2021 May 11, 2021	SELL	$108.84 - $128.23 $25,033 - $29,492	-230 Reduced 0.96%	23,700 $2.84 Million
Q4 2020 Feb 08, 2021	BUY	$105.0 - $114.42 $50,085 - $54,578	477 Added 2.03%	23,930 $2.62 Million
Q3 2020 Oct 28, 2020	BUY	$91.64 - $111.29 $55,442 - $67,330	605 Added 2.65%	23,453 $2.55 Million
Q2 2020 Aug 06, 2020	BUY	$76.57 - $98.0 $4,594 - $5,880	60 Added 0.26%	22,848 $2.09 Million
Q1 2020 Apr 28, 2020	BUY	$62.82 - $91.86 $4,837 - $7,073	77 Added 0.34%	22,788 $1.8 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $186,853 - $208,012	2,380 Added 11.71%	22,711 $1.97 Million
Q3 2019 Nov 08, 2019	SELL	$81.84 - $88.74 $96,162 - $104,269	-1,175 Reduced 5.46%	20,331 $1.7 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $1,390 - $1,681	-21 Reduced 0.1%	21,506 $1.72 Million
Q3 2018 Nov 08, 2018	SELL	$60.81 - $73.36 $6,689 - $8,069	-110 Reduced 0.51%	21,527 $1.58 Million
Q1 2018 May 09, 2018	BUY	$56.27 - $63.62 $42,821 - $48,414	761 Added 3.65%	21,637 $1.3 Million
Q4 2017 Feb 12, 2018	BUY	$53.68 - $57.47 $1,127 - $1,206	21 Added 0.1%	20,876 $1.19 Million
Q2 2017 Aug 09, 2017	BUY	N/A	20,855	20,855 $1.01 Million

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $202B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Guyasuta Investment Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Guyasuta Investment Advisors Inc with notifications on news.

Account

Guyasuta Investment Advisors Inc Abbott Laboratories Transaction History